D Asri, D Touboul, P Fournié, F Malet, C Garra… - Journal of Cataract & …, 2011 - Elsevier
PURPOSE: To report refractive, topographic, and biomechanical outcomes, efficiency, and
safety of corneal collagen crosslinking (CXL) 1, 3, 6, and 12 months after treatment …